Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus.

OBJECTIVE To investigate the role of the novel cytokine high mobility group box chromosomal protein 1 (HMGB-1) in the pathogenesis of cutaneous lupus erythematosus (CLE). METHODS Punch biopsy specimens of lesional and unaffected skin from 10 patients with CLE and 3 healthy control subjects were investigated. Immunohistochemical staining for HMGB-1, tumor necrosis factor alpha (TNFalpha), and interleukin-1beta (IL-1beta) was performed on consecutive sections. Analysis of single-nucleotide polymorphisms of -308 TNF was performed on DNA extracted from peripheral blood mononuclear cells. RESULTS An altered expression of HMGB-1 was observed both in the epidermis and in the dermal infiltrates of lesional skin. Expression of HMGB-1 in the epidermis and dermis was increased (P < 0.01 and P < 0.001, respectively, versus unaffected skin), and translocation to the cytoplasm as well as the extracellular presence of secreted HMGB-1 were found. Increased levels of TNFalpha and IL-1beta were also observed in the dermal infiltrates of lesional skin (P < 0.01 and P < 0.05, respectively, versus unaffected skin). The carrier frequency of the -308A TNF polymorphism was 80% in patients with subacute CLE, but this was not related to higher expression of TNFalpha in biopsy specimens from the CLE group. CONCLUSION The high amount of extracellular HMGB-1 observed in skin lesions indicates that HMGB-1 is involved in the inflammatory process of CLE. TNFalpha and IL-1beta may form a proinflammatory loop with HMGB-1, since they can induce the release of each other. The extracellular HMGB-1 observed by immunostaining of the epidermis indicates that keratinocytes may be an as yet unrecognized source of secreted HMGB-1, underscoring the role of the target organ in the rheumatoid autoimmune inflammatory process.

[1]  D. Isenberg,et al.  New therapies for systemic lupus erythematosus , 2005, Clinical and experimental immunology.

[2]  U. Andersson,et al.  RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages , 2005, Scandinavian journal of immunology.

[3]  S. Hanauer,et al.  A lupus-like syndrome associated with infliximab therapy. , 2003, Inflammatory bowel diseases.

[4]  K. Tracey,et al.  HMGB1 as a DNA‐binding cytokine , 2002, Journal of leukocyte biology.

[5]  M. Bianchi,et al.  The nuclear protein HMGB1 is secreted by monocytes via a non‐classical, vesicle‐mediated secretory pathway , 2002, EMBO reports.

[6]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[7]  Najia Shakoor,et al.  Drug-induced systemic lupus erythematosus associated with etanercept therapy , 2002, The Lancet.

[8]  D. Vestweber,et al.  Characterization of the inflammatory infiltrate and expression of endothelial cell adhesion molecules in lupus erythematosus tumidus , 2002, Archives of Dermatological Research.

[9]  L. Padyukov,et al.  Different allelic frequencies of several cytokine genes in Hong Kong Chinese and Swedish Caucasians , 2001, Genes and Immunity.

[10]  T. Ruzicka,et al.  Phototesting in lupus erythematosus: a 15-year experience. , 2001, Journal of the American Academy of Dermatology.

[11]  Wei Zhang,et al.  Association of a promoter polymorphism of tumor necrosis factor-alpha with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription. , 2000, The Journal of investigative dermatology.

[12]  K. Tracey,et al.  HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.

[13]  P. Puska,et al.  Occurrence of polymorphous light eruption in lupus erythematosus , 1997, The British journal of dermatology.

[14]  L. Walsh.  Ultraviolet B irradiation of skin induces mast cell degranulation and release of tumour necrosis factor‐α , 1995, Immunology and cell biology.

[15]  M. Flaig,et al.  Histologic Findings in Cutaneous Lupus Erythematosus , 1992 .

[16]  T. Luger,et al.  Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light , 1990, The Journal of experimental medicine.

[17]  R. Sontheimer.  Subacute cutaneous lupus erythematosus: a decade's perspective. , 1989, The Medical clinics of North America.

[18]  T. Kupper,et al.  Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. , 1987, The Journal of clinical investigation.

[19]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[20]  R. Sontheimer,et al.  Distinctive cutaneous subsets in the spectrum of lupus erythematosus. , 1981, Journal of the American Academy of Dermatology.

[21]  G. Goodwin,et al.  A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. , 1973, European journal of biochemistry.